思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01244 思路迪医药股份

未开盘 01-27 15:56:02

5.000

+0.190

+3.95%

最高5.000	最低4.630	成交量17.20万
今开4.810	昨收4.810	日振幅7.69%
总市值12.90亿	流通市值12.90亿	总股本2.58亿
成交额82.66万	换手率0.07%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01244","market":"HK","secType":"STK","nameCN":"思路迪医药股份","latestPrice":5,"timestamp":1769500562600,"preClose":4.81,"halted":0,"volume":172000,"delay":0,"changeRate":0.039501039501039586,"floatShares":258000000,"shares":258000000,"eps":-0.745688,"marketStatus":"未开盘","change":0.19,"latestTime":"01-27 15:56:02","open":4.81,"high":5,"low":4.63,"amount":826630,"amplitude":0.076923,"askPrice":5.1,"askSize":2000,"bidPrice":4.82,"bidSize":8000,"shortable":0,"etf":0,"ttmEps":-0.716,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769563800000},"marketStatusCode":0,"adr":0,"listingDate":1671033600000,"exchange":"SEHK","adjPreClose":4.81,"openAndCloseTimeList":[[1769477400000,1769486400000],[1769490000000,1769500800000]],"volumeRatio":1.2121212121212122,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01244","defaultTab":"news","newsList":[{"id":"2606221771","title":"思路迪医药股份盘中异动 早盘股价大跌5.81%报4.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606221771","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606221771?lang=zh_cn&edition=full","pubTime":"2026-01-26 11:02","pubTimestamp":1769396565,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘11时02分，思路迪医药股份股票出现异动，股价急速下跌5.81%。截至发稿，该股报4.700港元/股，成交量11.4万股，换手率0.04%，振幅7.82%。资金方面，该股资金流入2545港元，流出54.4935万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.76%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126110246a45598f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126110246a45598f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2605416857","title":"思路迪医药股份盘中异动 快速下跌6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605416857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605416857?lang=zh_cn&edition=full","pubTime":"2026-01-22 15:33","pubTimestamp":1769067232,"startTime":"0","endTime":"0","summary":"2026年01月22日临近收盘15时33分，思路迪医药股份股票出现波动，股价快速下跌6.77%。截至发稿，该股报4.820港元/股，成交量9.7万股，换手率0.04%，振幅6.96%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.56%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事肿瘤治疗药物的研究和开发的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122153352953ddb0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122153352953ddb0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2605485662","title":"思路迪医药股份盘中异动 大幅拉升6.92%报5.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605485662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605485662?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:12","pubTimestamp":1768975971,"startTime":"0","endTime":"0","summary":"2026年01月21日下午盘14时12分，思路迪医药股份股票出现波动，股价快速上涨6.92%。截至发稿，该股报5.560港元/股，成交量2.6万股，换手率0.01%，振幅6.92%。资金方面，该股资金流入3.424万港元，流出9.3775万港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.00%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114125197a2b564&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012114125197a2b564&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2604404118","title":"思路迪医药股份盘中异动 早盘股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604404118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604404118?lang=zh_cn&edition=full","pubTime":"2026-01-20 10:35","pubTimestamp":1768876551,"startTime":"0","endTime":"0","summary":"2026年01月20日早盘10时35分，思路迪医药股份股票出现异动，股价急速下跌6.35%。截至发稿，该股报5.160港元/股，成交量1.8万股，换手率0.01%，振幅6.35%。思路迪医药股份股票所在的生物技术行业中，整体跌幅为2.14%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120103551a43f017e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120103551a43f017e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2603779938","title":"思路迪医药股份盘中异动 股价大跌5.56%报5.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603779938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603779938?lang=zh_cn&edition=full","pubTime":"2026-01-15 10:37","pubTimestamp":1768444664,"startTime":"0","endTime":"0","summary":"2026年01月15日早盘10时37分，思路迪医药股份股票出现异动，股价急速下跌5.56%。截至发稿，该股报5.600港元/股，成交量9500股，换手率0.00%，振幅5.40%。资金方面，该股资金流入5880港元，流出4.94万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.63%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011510374497a1e0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011510374497a1e0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602543046","title":"思路迪医药股份(01244)委任陆孝皓为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2602543046","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602543046?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:03","pubTimestamp":1768226594,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)公布，张竞女士已正式辞去公司首席财务官职务;陆孝皓先生已获任命为首席财务官，上述任命即日起生效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2602716213","title":"思路迪医药股份(01244)：恩维达®一线胆道癌新药上市申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2602716213","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602716213?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:05","pubTimestamp":1767967506,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，国家药品监督管理局(NMPA)已正式受理公司商业化产品恩维达® (通用名：恩沃利单抗注射液，原研代号：KN035)联合吉西他滨和奥沙利铂(GEMOX)方案，用于一线治疗不可切除或转移性胆道癌 (BTC)的新药上市申请(NDA)。此次受理基于III期临床试验(KN035-CN-005)的临床研究结果，这是一项针对中国晚期一线胆道癌患者设计的随机、平行对照、多中心III期临床试验，旨在评估恩维达®(KN035)联合GEMOX方案对比单纯GEMOX方案的疗效与安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"思路迪医药股份(01244)：恩维达®一线胆道癌新药上市申请获国家药监局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2602134108","title":"思路迪医药股份盘中异动 急速上涨6.08%报5.580港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602134108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602134108?lang=zh_cn&edition=full","pubTime":"2026-01-09 10:15","pubTimestamp":1767924914,"startTime":"0","endTime":"0","summary":"2026年01月09日早盘10时15分，思路迪医药股份股票出现异动，股价急速拉升6.08%。截至发稿，该股报5.580港元/股，成交量7.4万股，换手率0.03%，振幅6.46%。资金方面，该股资金流入39.4655万港元，流出5315港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，瑞博生物-B、博安生物、思路迪医药股份涨幅较大，振幅较大的相关个股有拨康视云-B、瑞博生物-B、博安生物，振幅分别为19.19%、16.47%、9.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109101514953c4200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109101514953c4200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2600064872","title":"思路迪医药股份盘中异动 早盘大幅下挫6.00%报5.010港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600064872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600064872?lang=zh_cn&edition=full","pubTime":"2026-01-02 10:06","pubTimestamp":1767319585,"startTime":"0","endTime":"0","summary":"2026年01月02日早盘10时06分，思路迪医药股份股票出现波动，股价急速下跌6.00%。截至发稿，该股报5.010港元/股，成交量2.05万股，换手率0.01%，振幅0.38%。资金方面，该股资金流入0港元，流出10.2995万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，帝王国际投资、云康集团、中国抗体-B涨幅较大，振幅较大的相关个股有科笛-B、北海康成-B、轩竹生物-B，振幅分别为11.01%、9.77%、9.29%。该公司主要在中国国内市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102100625953be67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102100625953be67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2593464505","title":"思路迪医药股份(01244.HK)涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593464505","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593464505?lang=zh_cn&edition=full","pubTime":"2025-12-23 14:14","pubTimestamp":1766470491,"startTime":"0","endTime":"0","summary":"每经AI快讯，思路迪医药股份(01244.HK)涨近7%，截至发稿涨6.77%，报4.73港元，成交额91.12万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233599400621.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233599400621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2593043352","title":"思路迪医药股份(01244)：恩维达®胃癌和胃食管结合部癌适应症获孤儿药资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2593043352","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593043352?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:12","pubTimestamp":1766412751,"startTime":"0","endTime":"0","summary":"智通财经APP讯，思路迪医药股份(01244)发布公告，旗下商业化产品恩维达® (通用名：恩沃利单抗注射液，原研代号：KN035)针对胃癌和胃食管结合部癌适应症正式获得孤儿药资格认定，这是恩维达®继胆管癌和软组织肉瘤适应症后成功获批的第叁个孤儿药适应症。此次获批基于本公司开展的恩维达®晚期胃/食管胃结合部腺癌的II期临床研究展现出明确的抗肿瘤疗效，其联合FOLFOX方案的客观缓解率达60%，疾病控制率高达100%，且安全性与耐受性良好，无导致治疗终止或死亡的不良事件发生。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384635.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"1168608302","title":"思路迪医药股份 - 中国Nmpa对胃癌及胃食管交界癌的治疗指征认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1168608302","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168608302?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:11","pubTimestamp":1766412675,"startTime":"0","endTime":"0","summary":"思路迪医药股份 - 中国Nmpa对胃癌及胃食管交界癌的治疗指征认定","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2591983377","title":"中核集团攻克富集靶材辐照制备碘-131全链条技术 核药市场呈现高速增长（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2591983377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591983377?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:41","pubTimestamp":1765845673,"startTime":"0","endTime":"0","summary":"平台充分发挥集团内部协同创新优势，整合中国原子能所属核理化院、核动力院、中核高通、中核二七二铀业，攻克富集 TeO 靶材辐照制备碘-131全产业链技术，形成了从碘-131前置核素制备、反应堆辐照到核药研发的完整环境友好型自主产业链。中国同位素与辐射行业协会秘书长郭丽莉介绍，截至2024年，国家药监局批准上市的放射治疗设备超90款，其中国产品牌占比超七成，彻底改变了此前依赖进口设备的局面。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216090508a6a717ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1191","00512","BK1161","01763","BK1222"],"gpt_icon":0},{"id":"1155968992","title":"思路迪医药（1244）2025年11月股份变动月报：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1155968992","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155968992?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:50","pubTimestamp":1764820225,"startTime":"0","endTime":"0","summary":"思路迪医药股份有限公司于2025年12月4日披露2025年11月股份变动月报。数据显示，公司期内股本结构维持不变。已发行股份于11月底仍为258,177,000股，与上月底持平，未有新增发行或股份回购活动。整体而言，当月股本总数无变化。思路迪医药在公告中重申，已严格遵守香港联交所《上市规则》及其他适用法律规定。该份月报由董事龔兆龍正式签署并提交。公司股本截至11月底仍保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01244"],"gpt_icon":0},{"id":"2586735456","title":"临港浦江国际科技城企业思路迪诊断呼吸道病原体核酸检测试剂盒获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2586735456","media":"上海临港600848","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586735456?lang=zh_cn&edition=full","pubTime":"2025-11-27 23:45","pubTimestamp":1764258328,"startTime":"0","endTime":"0","summary":"11月25日，由临港浦江国际科技城企业思路迪推出的“四项呼吸道病原体核酸检测试剂盒”获国家药品监督管理局批准上市。值得关注的是，这并非思路迪首次在快速核酸检测领域实现突破。延伸阅读临港浦江国际科技城临港浦江国际科技城位于上海市中心城区南翼，黄浦江东岸，距离前滩商务区5公里，距离人民广场市中心16公里，地理位置优越，交通便捷。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128012137a4be9092&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128012137a4be9092&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02060","BK1183","01244"],"gpt_icon":0},{"id":"2585522581","title":"思路迪医药股份盘中异动 股价大跌6.43%报4.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585522581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585522581?lang=zh_cn&edition=full","pubTime":"2025-11-20 13:41","pubTimestamp":1763617273,"startTime":"0","endTime":"0","summary":"2025年11月20日下午盘13时41分，思路迪医药股份股票出现异动，股价大幅下挫6.43%。截至发稿，该股报4.800港元/股，成交量2500股，换手率0.00%，振幅4.87%。资金方面，该股资金流入0港元，流出1.214万港元。思路迪医药股份股票所在的生物技术行业中，整体涨幅为0.78%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120134113950ff52e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120134113950ff52e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2584959382","title":"思路迪医药股份11月18日遭主力抛售40.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584959382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584959382?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453739,"startTime":"0","endTime":"0","summary":"11月18日, 思路迪医药股份股价跌9.31%，报收4.87元，成交金额259.0万元，换手率0.21%，振幅18.44%，量比4.16。思路迪医药股份今日主力资金净流出40.8万元，上一交易日主力净流出25.8万元。该股近5个交易日下跌12.14%，主力资金累计净流出37.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出45.3万元，其中净流出天数为4日。该股主力净额占比0.03%，港股市场排名2431/2688。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181619079770b3df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511181619079770b3df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0},{"id":"2584624001","title":"思路迪医药股份盘中异动 下午盘股价大跌5.37%报4.930港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584624001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584624001?lang=zh_cn&edition=full","pubTime":"2025-11-17 15:20","pubTimestamp":1763364019,"startTime":"0","endTime":"0","summary":"2025年11月17日下午盘15时20分，思路迪医药股份股票出现异动，股价大幅下挫5.37%。截至发稿，该股报4.930港元/股，成交量10.75万股，换手率0.04%，振幅6.91%。资金方面，该股资金流入11.594万港元，流出43.0715万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。思路迪医药股份股票所在的生物技术行业中，整体跌幅为3.49%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117152019a6feb868&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117152019a6feb868&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2583540467","title":"思路迪医药股份盘中异动 股价大涨6.32%报5.380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583540467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583540467?lang=zh_cn&edition=full","pubTime":"2025-11-14 09:48","pubTimestamp":1763084937,"startTime":"0","endTime":"0","summary":"2025年11月14日早盘09时48分，思路迪医药股份股票出现波动，股价快速上涨6.32%。截至发稿，该股报5.380港元/股，成交量500股，换手率0.00%，振幅0.00%。资金方面，该股资金流入2690港元，流出0港元。思路迪医药股份股票所在的生物技术行业中，整体跌幅为1.69%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111409485795036bd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111409485795036bd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01244","BK1161"],"gpt_icon":0},{"id":"2582349803","title":"思路迪医药股份盘中异动 下午盘股价大跌5.62%报5.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582349803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582349803?lang=zh_cn&edition=full","pubTime":"2025-11-12 13:24","pubTimestamp":1762925083,"startTime":"0","endTime":"0","summary":"2025年11月12日下午盘13时24分，思路迪医药股份股票出现波动，股价快速跳水5.62%。截至发稿，该股报5.210港元/股，成交量2.15万股，换手率0.01%，振幅4.35%。资金方面，该股资金流入2725港元，流出11.196万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。思路迪医药股份股票所在的生物技术行业中，整体涨幅为4.12%。思路迪医药股份公司简介：思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112132443a49b7ae7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112132443a49b7ae7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01244"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3d-medicines.com","stockEarnings":[{"period":"1week","weight":-0.0385},{"period":"1month","weight":0.0504},{"period":"3month","weight":-0.2101},{"period":"6month","weight":-0.3179},{"period":"1year","weight":0.7921},{"period":"ytd","weight":-0.0619}],"compareEarnings":[{"period":"1week","weight":0.0241},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.0296},{"period":"6month","weight":0.095},{"period":"1year","weight":0.3431},{"period":"ytd","weight":0.0584}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"思路迪医药股份有限公司是一家主要从事生物制药研发及商业化业务的投资控股公司。该公司专注于肿瘤慢病化治疗领域的创新药物发现、开发及商业化，同时布局肿瘤疼痛管理领域。该公司已经构建一套完整的公司内部研发体系，已实现了从药物发现，临床前开发，临床试验、注册的全流程覆盖。该公司第一款上市药物恩维达是一款用于治疗泛瘤种的皮下注射PD-L1抑制剂。该公司还拥有多项创新药研发管线。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.022881},{"month":2,"riseRate":1,"avgChangeRate":0.184703},{"month":3,"riseRate":0.333333,"avgChangeRate":0.065195},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.025133},{"month":5,"riseRate":0.666667,"avgChangeRate":0.093531},{"month":6,"riseRate":0.333333,"avgChangeRate":0.03295},{"month":7,"riseRate":0.333333,"avgChangeRate":0.019677},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.195829},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.13358},{"month":10,"riseRate":0,"avgChangeRate":-0.260453},{"month":11,"riseRate":0,"avgChangeRate":-0.194469},{"month":12,"riseRate":0.666667,"avgChangeRate":0.250685}],"exchange":"SEHK","name":"思路迪医药股份","nameEN":"3D MEDICINES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"思路迪医药股份,01244,思路迪医药股份股票,思路迪医药股份股票老虎,思路迪医药股份股票老虎国际,思路迪医药股份行情,思路迪医药股份股票行情,思路迪医药股份股价,思路迪医药股份股市,思路迪医药股份股票价格,思路迪医药股份股票交易,思路迪医药股份股票购买,思路迪医药股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"思路迪医药股份(01244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供思路迪医药股份(01244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}